Osteoclasts and CD8 T cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Buchwald, Zachary S ^a   Aurora, Rajeev ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PHOSPHATE; REGULATOR PROTEIN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

AUTOREGULATION; B LYMPHOCYTE; BONE DENSITY; BONE EROSION; BONE MASS; BONE REMODELING; BONE TURNOVER; CD8+ T LYMPHOCYTE; EFFECTOR CELL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; MEDIATOR; MUSCULOSKELETAL SYSTEM; NEGATIVE FEEDBACK; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOID; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; BONE; CELL COMMUNICATION; CYTOLOGY; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

BONE AND BONES; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; OSTEOCLASTS; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 84880168524     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/429373     Document Type: Review

References (83)

1. Arron J. R., Choi Y., Bone versus immune system. Nature 2000 408 6812 535 536 2-s2.0-0034735792 10.1038/35046196
2. David J., Osteoimmunology: a view from the bone. Advances in Immunology 2007 95 149 165 2-s2.0-34548494841 10.1016/S0065-2776(07)95005-1 (Pubitemid 47380505)
3. Sato K., Takayanagi H., Osteoclasts, rheumatoid arthritis, and osteoimmunology. Current Opinion in Rheumatology 2006 18 4 419 426 2-s2.0-33748032383 10.1097/01.bor.0000231912.24740.a5 (Pubitemid 44297289)
4. Takayanagi H., Sato K., Takaoka A., Taniguchi T., Interplay between interferon and other cytokine systems in bone metabolism. Immunological Reviews 2005 208 181 193 2-s2.0-28544442029 (Pubitemid 41746393)
5. Mossetti G., Rendina D., de Filippo G., Viceconti R., Di Domenico G., Cioffi M., Postiglione L., Nunziata V., Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment. Bone 2005 36 3 549 554 2-s2.0-15544379426 10.1016/j.bone.2004.11.004 (Pubitemid 40403853)
6. Rodan G. A., Martin T. J., Therapeutic approaches to bone diseases. Science 2000 289 5484 1508 1514 2-s2.0-0034284550 10.1126/science.289.5484.1508
7. Pacifici R., Estrogen deficiency, T cells and bone loss. Cellular Immunology 2008 252 1-2 68 80 2-s2.0-48149084609 10.1016/j.cellimm.2007.06.008
8. Chatenoud L., Protection from autoimmunity: immunological indifference versus T-cell mediated suppression? European Journal of Immunology 2006 36 9 2296 2298 2-s2.0-33748880096 10.1002/eji.200636591 (Pubitemid 44420585)
9. Joller N., Peters A., Anderson A. C., Kuchroo V. K., Immune checkpoints in central nervous system autoimmunity. Immunological Reviews 2012 248 1 122 139 10.1111/j.1600-065X.2012.01136.x
10. Richez C., Blanco P., Rifkin I., Moreau J., Schaeverbeke T., Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011 78 2 124 130 2-s2.0-79952245823 10.1016/j.jbspin.2010.09.005
11. Lacroix-Desmazes S., Mouthon L., Spalter S. H., Kaveri S., Kazatchkine M. D., Immunoglobulins and the regulation of autoimmunity through the immune network. Clinical and Experimental Rheumatology 1996 14 supplement 15 S9 S15 2-s2.0-0029782115 (Pubitemid 26270572)
12. Murray P. J., Smale S. T., Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nature Immunology 2012 13 10 916 924 10.1038/ni.2391
13. Bekker P. J., Holloway D. L., Rasmussen A. S., Murphy R., Martin S. W., Leese P. T., Holmes G. B., Dunstan C. R., DePaoli A. M., A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. Journal of Bone and Mineral Research 2004 19 7 1059 1066 2-s2.0-3342982829 10.1359/JBMR.040305 (Pubitemid 41110556)
14. Saraiva M., O'Garra A., The regulation of IL-10 production by immune cells. Nature Reviews Immunology 2010 10 3 170 181 2-s2.0-77649184739 10.1038/nri2711
15. + T-cell polarization by suppressor of cytokine signalling proteins. Immunology 2012 135 2 101 111 2-s2.0-84855832580 10.1111/j.1365-2567.2011.03520.x
16. Lang T., Mansell A., The negative regulation of toll-like receptor and associated pathways. Immunology and Cell Biology 2007 85 6 425 434 2-s2.0-34548436187 10.1038/sj.icb.7100094 (Pubitemid 47367504)
17. Appleby M. W., Ramsdell F., Scurfy, the Foxp3 locus, and the molecular basis of peripheral tolerance. Current Topics in Microbiology and Immunology 2008 321 151 168 2-s2.0-51149100362 10.1007/978-3-540-75203-5-7
18. + Tregs using the DEREG mouse model. Methods in Molecular Biology 2011 707 157 172 2-s2.0-79955700323 10.1007/978-1-61737-979-6-10
19. Piccirillo C. A., Regulatory T cells in health and disease. Cytokine 2008 43 3 395 401 2-s2.0-51349168951 10.1016/j.cyto.2008.07.469
20. + regulatory T cells in the human immune system. Nature Reviews Immunology 2010 10 7 490 500 2-s2.0-77954141914 10.1038/nri2785
21. + regulatory T cells. Immunological Reviews 2006 212 60 73 2-s2.0-33746365086 10.1111/j.0105-2896.2006.00415.x (Pubitemid 44116700)
22. Rudensky A., Foxp3 and dominant tolerance. Philosophical Transactions of the Royal Society B 2005 360 1461 1645 1646 10.1098/rstb.2005.1731 (Pubitemid 43997812)
23. + T-cell tolerance induced by steady-state dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2010 107 1 199 203 2-s2.0-76249119192 10.1073/pnas.0910620107
24. Germain R. N., Maintaining system homeostasis: the third law of Newtonian immunology. Nature Immunology 2012 13 10 902 906 10.1038/ni.2404
25. + T cell effector pool size via IL-2 restriction. Journal of Immunology 2011 187 6 3186 3197 2-s2.0-80053063763 10.4049/jimmunol.1101649
26. Mempel T. R., Pittet M. J., Khazaie K., Weninger W., Weissleder R., von Boehmer H., von Andrian U. H., Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006 25 1 129 141 2-s2.0-33745978399 10.1016/j.immuni.2006.04.015 (Pubitemid 44066829)
27. Kular J., Tickner J., Chim S. M., Xu J., An overview of the regulation of bone remodelling at the cellular level. Clinical Biochemistry 2012 45 12 863 873 2-s2.0-84859410567 10.1016/j.clinbiochem.2012.03.021
28. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J. Q., Bonewald L. F., Kodama T., Wutz A., Wagner E. F., Penninger J. M., Takayanagi H., Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nature Medicine 2011 17 10 1231 1234 2-s2.0-80053938104 10.1038/nm.2452
29. Xiong J., Onal M., Jilka R. L., Weinstein R. S., Manolagas S. C., O'Brien C. A., Matrix-embedded cells control osteoclast formation. Nature Medicine 2011 17 10 1235 1241 2-s2.0-80053978532 10.1038/nm.2448
30. Klein-Nulend J., Bacabac R. G., Bakker A. D., Mechanical loading and how it affects bone cells: the role of the osteocyte cytoskeleton in maintaining our skeleton. European Cells and Materials 2012 24 278 291
31. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., Suda T., Matsuo K., Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metabolism 2006 4 2 111 121 2-s2.0-33746528704 10.1016/j.cmet.2006.05.012 (Pubitemid 44138718)
32. Wong B. R., Josien R., Choi Y., TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. Journal of Leukocyte Biology 1999 65 6 715 724 2-s2.0-0000371126 (Pubitemid 29279518)
33. Kung Y., Felge U., Sarosi I., Bolon B., Taturi A., Morony S., Capparelli C., Li J., Elliott R., McCabe S., Wong T., Campagnuolo G., Moran E., Bogoch E. R., Van G., Nguyen L. T., Ohashi P. S., Lacey D. L., Fish E., Boyle W. J., Penninger J. M., Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999 402 6759 304 309 2-s2.0-0033581952 10.1038/46303 (Pubitemid 129516268)
34. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., Takaoka A., Yokochi T., Oda H., Tanaka K., Nakamura K., Taniguchi T., T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN- γ Nature 2000 408 6812 600 605 2-s2.0-0034735773 10.1038/35046102
35. Li Y., Toraldo G., Li A., Yang X., Zhang H., Qian W., Weitzmann M. N., B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 2007 109 9 3839 3848 2-s2.0-34247323904 10.1182/blood-2006-07-037994 (Pubitemid 46641735)
36. Weitzmann M. N., The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica 2013 2013 29 125705 10.1155/2013/125705
37. Kiesel J., Miller C., Abu-Amer Y., Aurora R., Systems level analysis of osteoclastogenesis reveals intrinsic and extrinsic regulatory interactions. Developmental Dynamics 2007 236 8 2181 2197 2-s2.0-34548058081 10.1002/dvdy.21206 (Pubitemid 47293761)
38. + T cells. Journal of Immunology 2009 182 9 5477 5487 2-s2.0-66949172165 10.4049/jimmunol.0803897
39. + T cells. Blood 2010 116 2 210 217 2-s2.0-77955475327 10.1182/blood-2009-11-255026
40. + T-cells suppress bone resorption in vitro. PLoS ONE 2012 7 e38199 10.1371/journal.pone.0038199
41. + CD8 T-cells can suppress bone turnover in response to RANKL administration and in ovariectomized mice. Bone. In press
42. + T cells. European Journal of Immunology 2001 31 7 2179 2188 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X (Pubitemid 32640735)
43. + T lymphocytes in osteoclast differentiation in vitro. Endocrinology 1996 137 6 2457 2463 2-s2.0-0029938143 10.1210/en.137.6.2457 (Pubitemid 26155782)
44. Grcevic D., Lee S. K., Marusic A., Lorenzo J. A., Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. Journal of Immunology 2000 165 8 4231 4238 2-s2.0-0034667933
45. Zaiss M. M., Axmann R., Zwerina J., Polzer K., Gückel E., Skapenko A., Schulze-Koops H., Horwood N., Cope A., Schett G., Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis and Rheumatism 2007 56 12 4104 4112 2-s2.0-37149026641 10.1002/art.23138 (Pubitemid 350262338)
46. Zaiss M. M., Frey B., Hess A., Zwerina J., Luther J., Nimmerjahn F., Engelke K., Kollias G., Hünig T., Schett G., David J., Regulatory T cells protect from local and systemic bone destruction in arthritis. Journal of Immunology 2010 184 12 7238 7246 2-s2.0-77953639101 10.4049/jimmunol.0903841
47. Zaiss M. M., Sarter K., Hess A., Engelke K., Böhm C., Nimmerjahn F., Voll R., Schett G., David J., Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. Arthritis and Rheumatism 2010 62 8 2328 2338 2-s2.0-77955373402 10.1002/art.27535
48. + regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype? Human Immunology 2008 69 11 696 699 2-s2.0-57649099846 10.1016/j.humimm.2008.08. 291
49. + T cells induced by a humanized OKT3 monoclonal antibody hOKT3 γ 1(Ala-Ala). Human Immunology 2008 69 11 732 736 2-s2.0-57649095902 10.1016/j.humimm.2008.08.290
50. + T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002 123 5 1516 1526 2-s2.0-0036828289 (Pubitemid 35231652)
51. + regulatory T cells in multiple sclerosis. Annals of Neurology 2010 67 5 625 638 2-s2.0-77951712594 10.1002/ana.21944
52. + regulatory T cells. Nature Immunology 2003 4 4 330 336 2-s2.0-0037385330 10.1038/ni904 (Pubitemid 36432314)
53. Gavin M. A., Rasmussen J. P., Fontenot J. D., Vasta V., Manganiello V. C., Beavo J. A., Rudensky A. Y., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007 445 7129 771 775 2-s2.0-33847153417 10.1038/nature05543 (Pubitemid 46279714)
54. + T cells and self-nonself discrimination: an essay on peripheral T-cell regulation. Human Immunology 2008 69 11 721 727 2-s2.0-57649083400 10.1016/j.humimm.2008. 08.279
55. + T cells similar to those found in mice with anterior chamber-associated immune deviation. Investigative Ophthalmology and Visual Science 2000 41 7 1803 1811 2-s2.0-0034122206 (Pubitemid 30354352)
56. + T regulatory cells. Nature Immunology 2003 4 4 337 342 2-s2.0-0037385314 10.1038/ni909 (Pubitemid 36432315)
57. + regulatory T cells mediate immunosuppression in prostate cancer. Clinical Cancer Research 2007 13 23 6947 6958 2-s2.0-37249067503 10.1158/1078-0432.CCR-07-0842 (Pubitemid 350276874)
58. - T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Human Immunology 2006 67 1-2 1 12 2-s2.0-33646371011 10.1016/j.humimm.2005.11.005 (Pubitemid 43673918)
59. + T regulatory cells. Current Opinion in Immunology 2008 20 3 327 331 2-s2.0-45449108015 10.1016/j.coi.2008.02.003
60. Munsky B., Neuert G., van Oudenaarden A., Using gene expression noise to understand gene regulation. Science 2012 336 6078 183 187 2-s2.0-84859641038 10.1126/science.1216379
61. Alberts B., Wilson J. H., Hunt T., Molecular Biology of the Cell 2008 New York, NY, USA Garland Science
62. Shevach E. M., From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006 25 2 195 201 2-s2.0-33747143361 10.1016/j.immuni.2006.08.003 (Pubitemid 44224153)
63. + regulatory T cells participate in the control of immune responses. Journal of Immunology 2007 178 11 6901 6911 2-s2.0-34249806715 (Pubitemid 46847416)
64. + regulatory T cells by TGF- β induction of transcription factor Foxp3. Journal of Experimental Medicine 2003 198 12 1875 1886 2-s2.0-0348223787 10.1084/jem.20030152 (Pubitemid 38032120)
65. Blander J. M., Signalling and phagocytosis in the orchestration of host defence. Cellular Microbiology 2007 9 2 290 299 2-s2.0-33846234257 10.1111/j.1462-5822.2006.00864.x (Pubitemid 46092159)
66. Villadangos J. A., Schnorrer P., Wilson N. S., Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunological Reviews 2005 207 191 205 2-s2.0-26244465086 10.1111/j.0105-2896.2005.00317.x (Pubitemid 41415018)
67. + T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. Journal of Immunology 2012 189 5 2118 2130 10.4049/jimmunol.1200122
68. + regulatory T cells. The American Journal of Transplantation 2012 12 9 2335 2347 10.1111/j.1600-6143.2012.04120.x
69. + regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 2012 119 24 5898 5908 10.1182/blood-2011-12- 396119
70. Haribhai D., Lin W., Relland L. M., Truong N., Williams C. B., Chatila T. A., Regulatory T cells dynamically control the primary immune response to foreign antigen. Journal of Immunology 2007 178 5 2961 2972 2-s2.0-33847370194 (Pubitemid 46333175)
71. Morimoto R., Uehara S., Yatsushiro S., Juge N., Hua Z., Senoh S., Echigo N., Hayashi M., Mizoguchi T., Ninomiya T., Udagawa N., Omote H., Yamamoto A., Edwards R. H., Moriyama Y., Secretion of L-glutamate from osteoclasts through transcytosis. EMBO Journal 2006 25 18 4175 4186 2-s2.0-33748937528 10.1038/sj.emboj.7601317 (Pubitemid 44435215)
72. Schreiweis M. A., Butler J. P., Kulkarni N. H., Knierman M. D., Higgs R. E., Halladay D. L., Onyia J. E., Hale J. E., A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. Journal of Cellular Biochemistry 2007 101 2 466 476 2-s2.0-34247889970 10.1002/jcb.21196 (Pubitemid 46698879)
73. Gravallese E. M., Bone destruction in arthritis. Annals of the Rheumatic Diseases 2002 61 supplement 2 ii84 ii86 2-s2.0-0036839553 (Pubitemid 35221724)
74. + T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. Journal of Immunology 1996 156 11 4520 4526 2-s2.0-0030010969 (Pubitemid 26165856)
75. Borza D. B., Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis. Nephron-Experimental Nephrology 2007 106 2 e37 e43 2-s2.0-34447117525 10.1159/000101791 (Pubitemid 47202761)
76. Erlebacher A., Mechanisms of T cell tolerance towards the allogeneic fetus. Nature Reviews Immunology 2013 13 23 33 10.1038/nri3361
77. Pacifici R., Role of T cells in ovariectomy induced bone loss-revisited. Journal of Bone and Mineral Research 2012 27 2 231 239 2-s2.0-84856148387 10.1002/jbmr.1500
78. Adams G. B., Scadden D. T., The hematopoietic stem cell in its place. Nature Immunology 2006 7 4 333 337 2-s2.0-33645103515 10.1038/ni1331
79. Arai F., Hirao A., Suda T., Regulation of hematopoiesis and its interaction with stem cell niches. International Journal of Hematology 2005 82 5 371 376 2-s2.0-33646448451 10.1532/IJH97.05100 (Pubitemid 46638683)
80. Badillo A. T., Flake A. W., The regulatory role of stromal microenvironments in fetal hematopoietic ontogeny. Stem Cell Reviews 2006 2 3 241 246 2-s2.0-34547194164 10.1007/s12015-006-0052-5 (Pubitemid 47109402)
81. Haylock D. N., Nilsson S. K., Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 2005 4 10 1353 1355 2-s2.0-26444446918 (Pubitemid 41437120)
82. Kollet O., Dar A., Lapidot T., The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annual Review of Immunology 2007 25 51 69 2-s2.0-34247889894 10.1146/annurev.immunol.25. 022106.141631 (Pubitemid 46697902)
83. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., Tesio M., Samstein R. M., Goichberg P., Spiegel A., Elson A., Lapidot T., Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nature Medicine 2006 12 6 657 664 2-s2.0-33744983304 10.1038/nm1417 (Pubitemid 43865234)